171002-00-9Relevant academic research and scientific papers
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
-
Paragraph 0342, (2018/04/20)
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1).
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
-
Page/Page column 92, (2013/05/21)
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1)
BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS
-
Page/Page column 179-180, (2009/12/27)
The present invention relates to Bicyclic Heterocycle Derivatives of formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR1 19 in a patient.
Synthesis of chiral β-amino sulfides and β-amino thiols from α-amino acids
Cran,Gibson,Handa
, p. 1553 - 1556 (2007/10/02)
Bifurcated routes to two series of chiral secondary β-amino sulfides 5a-c and 11a-c have been developed from L-proline and (S)-phenylglycine, respectively. The developed methodology had also led to the synthesis of the tertiary β-amino thiol 7 and the primary β-amino sulfide 12 from L-proline and (S)-phenylglycine, respectively.
